Cysteamine Research Articles

Dual-mode colorimetric determination of As(III) based on negatively-charged aptamer-mediated aggregation of positively-charged AuNPs

The aggregation and redispersion of positively-charged AuNPs ((+)AuNPs) modified with cysteamine (CS) could be regulated by the negatively charged As(III)-specific aptamer (As(III)-apt). In general, (+)AuNPs aggregated with increasing inducer concentration. However, in the present study, it was found that (+)AuNPs re-dispersed after a certain high concentration of As(III)-apt was reached. By optimizing the concentration of As(III)-apt that resulted in the aggregation and redispersion behavior of (+)AuNPs, a dual-mode colorimetric aptasensor for As(III) determination was established. It was not only able to quantify As(III) sensitively over a ranges of As(III) concentrations, but also to selectively differentiate As(III) and eliminate false results from other control ions by dual-mode.

Skin Toxicity of Selected Hair Cosmetic Ingredients: A Review Focusing on Hairdressers.

The safety assessment of cosmetics considers the exposure of a ‘common consumer’, not the occupational exposure of hairdressers. This review aims to compile and appraise evidence regarding the skin toxicity of cysteamine hydrochloride (cysteamine HCl; CAS no. 156-57-0), polyvinylpyrrolidone (PVP; CAS no. 9003-39-8), PVP copolymers (CAS no. 28211-18-9), sodium laureth sulfate (SLES; CAS no. 9004-82-4), cocamide diethanolamine (cocamide DEA; CAS no. 68603-42-9), and cocamidopropyl betaine (CAPB; CAS no. 61789-40-0). A total of 298 articles were identified, of which 70 were included. Meta-analysis revealed that hairdressers have a 1.7-fold increased risk of developing a contact allergy to CAPB compared to controls who are not hairdressers. Hairdressers might have a higher risk of acquiring quantum sensitization against cysteamine HCl compared to a consumer because of their job responsibilities. Regarding cocamide DEA, the irritant potential of this surfactant should not be overlooked. Original articles for PVP, PVP copolymers, and SLES are lacking. This systematic review indicates that the current standards do not effectively address the occupational risks associated with hairdressers’ usage of hair cosmetics. The considerable irritant and/or allergenic potential of substances used in hair cosmetics should prompt a reassessment of current risk assessment practices.

Omeprazole treatment manifests anxiolytic effects in a cysteamine hydrochloride induced mouse model of gastrointestinal disorder

Omeprazole, a proton pump inhibitor (PPI), has widely been used to treat various gastrointestinal (GI) disorders. Notably, many clinical symptoms of GI disorders have been known to be associated with anxiety. In recent years, an exponentially increased number of subjects with abnormal ageing, neurological deficits, and psychiatric problems simultaneously exhibit GI dysfunctions as well as anxiety. Considering the fact, drugs that are used to treat GI disorders can be speculated to mitigate anxiety-related symptoms, and vice versa. Although, omeprazole treatment has been reported to result in development of anxiety and neurocognitive decline, ample reports suggest that omeprazole treatment is beneficial for the positive regulation of neuroplasticity. While underlying mechanisms of omeprazole-mediated neurological alterations remain obscure, the available scientific data on the omeprazole induced adverse effects in the brain appear to be inadequate, uncertain, and controversial. Hence, this study revisited the effect of omeprazole treatment on the degree of anxiety-like behaviours in a cysteamine hydrochloride (HCl) induced mouse model of GI disorder using open field test (OFT), light-dark box (LDB) test and elevated plus maze (EPM). Results revealed that omeprazole treatment mitigates anxiety-related behaviours in the cysteamine HCl induced animal model of GI disorder. Thus, this study assuredly supports and validates the anxiolytic properties of omeprazole. However, the adverse effects associated with inappropriate intake of omeprazole may not completely be excluded. Therefore, this study advocates the future direction in determining the long-term effects of omeprazole on the brain functions.

Synthesis of a Curing Agent Derived from Limonene and the Study of Its Performance to Polymerize a Biobased Epoxy Resin Using the Epoxy/Thiol-Ene Photopolymerization Technique.

This study describes the synthesis of a curing agent derived from limonene as well as its application to prepare biobased thermoset polymers via the epoxy/thiol-ene photopolymerization (ETE) method. A biobased commercial epoxy resin was used to synthesize a crosslinked polymeric matrix of polyether-polythioether type. The preparation of the curing agent required two steps. First, a diamine intermediate was prepared by means of a thiol-ene coupling reaction between limonene and cysteamine hydrochloride. Second, the primary amino groups of the intermediate compound were alkylated using allyl bromide. The obtained ditertiary amine-functionalized limonene compound was purified and characterized by FTIR and NMR spectroscopies along with GC-MS. The curing agent was formulated with a tetrafunctional thiol in stoichiometric ratio, and a photoinitiator at 1 mol % concentration, as the components of a thiol-ene system (TES). Two formulations were prepared in which molar concentrations of 30 and 40 mol % of the TES were added to the epoxy resin. The kinetics of the ETE photopolymerizations were determined by means of Real-Time FTIR spectroscopy, which demonstrated high reactivity by observing photopolymerization rates in the range of 1.50–2.25 s−1 for the epoxy, double bonds and thiol groups. The obtained polymers were analyzed by thermal and thermo-mechanical techniques finding glass transition temperatures (Tg) of 60 °C and 52 °C for the polymers derived from the formulations with 30 mol % and 40 mol % of TES, respectively. Potential applications for these materials can be foreseen in the area of coatings.

Dietary Cysteamine Supplementation Remarkably Increased Feed Efficiency and Shifted Rumen Fermentation toward Glucogenic Propionate Production via Enrichment of Prevotella in Feedlot Lambs.

Cysteamine (CS) is an essential nutritional regulator that improves the productive performance of animals by regulating somatotropic hormone secretion. To investigate the fattening potential and effects of CS on rumen microbial fermentation, 48 feedlot lambs were randomly assigned to four groups and fed diets supplemented with different CS concentrations (0, 20, 40, and 60 mg/kg BW). An increase in dietary CS concentrations linearly increased the average daily gain (ADG) and dry matter intake (p < 0.05) but decreased the feed-to-gain ratio (p < 0.01). For the serum hormone, increasing the dietary CS concentration linearly decreased somatostatin and leptin concentration (p < 0.01) but linearly increased the concentration of growth hormone and insulin-like growth factor 1 (p < 0.01). Regarding rumen fermentation, ruminal pH, ammonia-N, and butyrate content did not differ among the four treatments, although dietary CS supplementation linearly increased microbial protein and propionate and decreased the amount of acetate (p < 0.05). Furthermore, an increase in dietary CS concentrations quadratically decreased the estimated methane production and methane production per kg ADG (p < 0.05). High-throughput sequencing revealed that increased dietary CS concentrations quadratically increased Prevotella (p < 0.05), and Prevotella and norank_f__norank_o__Clostridia_UCG-014 were positively correlated with growth performance and rumen fermentation in a Spearman correlation analysis (r > 0.55, p < 0.05). Overall, a CS concentration higher than 20 mg/kg BW produced growth-promoting effects by inhibiting somatostatin concentrations and shifting the rumen toward glucogenic propionate fermentation by enriching Prevotella. In addition, Prevotella and norank_f__norank_o__Clostridia_UCG-014 were positively correlated with growth performance in lambs.

Efficient regioselective five-component synthesis of novel thiazolo[3,2-a]pyridine carbohydrazides and oxazolo[3,2-a]pyridine carbohydrazides.

Two new categories of fused pyridines include 2H-thiazolo[3,2-a]pyridine-6-carbohydrazides and 2H-oxazolo[3,2-a]pyridine-6-carbohydrazides have been successfully synthesized via five-component cascade reactions using 9-fluorenone, cyanoacetohydrazide, 1,1-bis(methylthio)-2-nitroethene, aromatic aldehydes and cysteamine hydrochloride or ethanol amine as starting materials. This new approach involves a subsequence of key steps: N,S-acetal or N,O-acetal formation, Knoevenagel condensation, Michael addition, tautomerization and N-cyclization. It also has some advantages, such as convenience of operation, tolerance of a wide diversity of functional groups, use of green solvent and ease of purification by washing the crude products with ethanol.

Improved adsorption and desorption behavior of Cd on thiol-modified bentonite grafted with cysteamine hydrochloride

Improved adsorption and desorption behavior of Cd on thiol-modified bentonite grafted with cysteamine hydrochloride

Functionalization and soft photoreduction of graphene oxide triggered by the photoinitiator during thiol-ene radical addition

Thiol-ene radical addition (TERA) is a powerful reaction for the chemical functionalization of the reactive alkenes of GO with thiols. To trigger TERA, a photoinitiator (PI) is added to ensure high yields associated with fast conversion rates. However, the inappropriate use of PIs might affect the GO functionalization leading to photoreduction as well as low conversion rates. Herein, we explored the GO functionalization with cysteamine (CA) by TERA and its reduction influenced by Irgacure® 369, a commercial PI. We focused to analyze the reaction conditions that promote an orthogonal GO functionalization finding the limits where the photoreduction began. UV-spectroscopy, Raman spectroscopy, fluorescence labeling and XPS were used to characterize the functionalized GO. The data indicate three possible scenarios depending on the PI/CA molar ratio: i) orthogonal GO functionalization by TERA, ii) side reactions between GO and the radicals formed upon the PI photocleavage, and iii) soft photoreduction of the GO with alcohols and carboxylic acids as the functional groups mainly affected. However, we found that the GO functionalization by TERA was still occurring, but in less favorable conditions despite the side reactions and by-products. Therefore, photo-initiated TERA was confirmed as a powerful reaction to functionalize the reactive alkenes of GO, and by tuning the PI/CA molar ratio an orthogonal GO functionalization can be achieved, limiting side reactions and particularly GO reduction.

Hydrophilic Gold Nanoparticles as Anti‐PD‐L1 Antibody Carriers: Synthesis and Interface Properties

AbstractAmino and sulfonate ending groups thiols are used as functionalizing agents to stabilize of gold nanoparticles (AuNPs), obtaining hydrophilic AuNPs with a 10–20 nm diameter range and tunable surface charge. The nanomaterial is extensively characterized from a physicochemical point of view by UV–Vis and Fourier‐transform infrared spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, synchrotron radiation X‐ray photoelectron spectroscopy (XPS), and dynamic light scattering to investigate the bonding between the two thiols and the metal surface. Systems are also biologically characterized on human multiforme glioblastoma T98G cells to understand their behavior in cell culture for biomedical applications. NMR and XPS studies evidence the presence of amino ending thiols with different chain lengths, 6‐amino‐1‐hexanethiol hydrochloride (6EA) or cysteamine (CY) and sodium 3‐mercapto‐1‐propanesulfonate (3MPS) on the metal surface: the relative molar ratio between the thiols bound to the AuNPs (3MPS/6EA or 3MPS/CY) is measured. On selected samples, the anti‐PD‐L1 antibody is loaded using AuNPs/antibody combination in a 2:1 weight ratio. Comparing different AuNPs concentrations (10 and 50 µg mL−1), the effect on colony‐forming capacity after 24 h exposure is evaluated. The synthesized AuNPs are nontoxic, and they do not affect cell proliferation. These small particles can be used for targeting, opening tangible and interesting perspectives for further biomedical studies.

Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops®)

PurposeThe aim of this study was to evaluate in vivo the tear film in infantile nephropathic cystinosis patients with corneal crystals treated with topical viscous cysteamine hydrochloride (Cystadrops®).MethodsTen eyes of five patients with nephropathic cystinosis aged from 10 to 35 years were included in this study. The patients were under treatment with viscous cysteamine hydrochloride formulation containing 3.8 mg/mL cysteamine (vCH 0.55%, equivalent to 0.55% CH; Cystadrops®; Recordati rare Diseases, Puteaux, France) to reduce corneal crystal density. Five age and sex matched individuals were randomly selected as control group. Tear osmolarity testing (TearLabTM) was performed to assess the in vivo osmolarity of patients under treatment and compared to control group values. Tear film break-up time (TBUT) and basic tear secretion (Schirmer test) were also assessed.ResultsMean tear osmolarity was 294.8 mOsms/L (±10.4), with a mean absolute difference of 1.85 mOsms/L (±2.13) between the eyes. There was no statistically significant difference between the osmolarity readings of cystinosis and the control group (294.8 ± 10.4 vs 299.4 ± 6.2mOsm/L, respectively; p = 0.39). The mean TBUT was 10.2 ± 0.83 s in the study group versus 10 ± 0.7 s in controls (p = 0.62). The mean Schirmer test score was 9.2 ± 0.83 mm in the patients versus 10.2 ± 0.83 mm in the controls (p = 0.14).ConclusionsThe TearLabTM osmolarity system test showed good reliability and precision in repeated measurements. This is the first report using the TearLab osmolarity system to assess tear film in patients with cystinosis treated with vCH 0.55%. TearLabTM examination showed that the use of vCH 0.55% drops does not determine alterations of the tear film quality.

Phytotoxicity of Silver Nanoparticles with Different Surface Properties on Monocots and Dicots Model Plants

The aim of the research was to evaluate the effect of three types of silver nanoparticles (AgNPs) with different physicochemical properties and silver ions delivered in the form of silver nitrate (AgNO3) at the concentration of 50 mg L−1 on germination and initial growth of monocots (common wheat, sorghum) and dicots (garden cress, white mustard). The AgNPs were prepared using trisodium citrate (TCSB-AgNPs), tannic acid (TA-AgNPs), and cysteamine hydrochloride (CHSB-AgNPs). They exhibited comparable shape, size distribution, and an average size equal to 15 ± 3 nm which was confirmed with the use of transmission electron microscopy. The electrokinetic characteristics revealed that CHSB-AgNPs have positive, whereas TCSB-AgNPs and TA-AgNPs negative surface charge. First, toxicity of the silver compounds was assessed using the Phytotestkit test. Next, after transferring seedlings to pots, shoot length, leaf surface, shoot dry mass, electrolyte leakage measurement, and photosystem II (PSII) efficiency were determined. AgNPs and silver ions delivered in the form of AgNO3 reduced root and shoots length of common wheat, sorghum, and garden cress; leaves surface of garden cress and white mustard; and shoots dry mass of white mustard. The positively charged CHSB-AgNPs and silver ions delivered in the form of AgNO3 showed the greatest inhibition effect. Moreover, silver ions and positively charged CHSB-AgNPs were more toxic to PSII of model plants than negatively charged TCSB-AgNPs and TA-AgNPs. AgNPs impact differed in the case of monocots and dicots, but the size of the changes was not significant, so it concerned individual parameters. The results revealed the interaction strength, which was generally similar in all tested plants, i.e., increasing negative effect in sequence TCSB-AgNPs < TA-AgNPs < silver ions delivered in the form of AgNO3 < CHSB-AgNPs.

Complexant-montmorillonite nanocomposites for heavy metal binding in sulfide tailing

Complexant-montmorillonite nanocomposites were successfully prepared through the intercalation of the complexants cysteamine hydrochloride (CSH), 1,6-diaminlhexane (DA), tetraethylenepentamine (TEPA) with different functional group and molecular weight in this work. More importantly, it was proved that the heavy metal stabilization property of montmorillonite improved significantly after intercalation of complexants through characterization by XRD and SEM-EDS. Here, the complexant-montmorillonite nanocomposites exhibited strong pH buffering effects. The Zn stabilization rate was prone to 100% by adding DA or TEPA modified montmorillonite (DA-Mt or TEPA-Mt) into the tailings, and the releasing rate of As and Mn from tailings also decreased greatly. Generally, the Zn, Pb, Mn and As stabilization effects of both TEPA-Mt and DA-Mt were much better than that of CSH modified montmorillonite, which suggested that the heavy metal complexing abilities of complexant-montmorillonite nanocomposites highly depended on the functional group and molecular weight of the complexants. In this study, electrostatic adsorption, physical adsorption, ion exchange and complexation worked together and produced good heavy metal stabilization effect. Our findings could provide an important reference for the synthesis of efficient stabilization nanomaterials.

Photoclick polysaccharide-based bioinks with an extended biofabrication window for 3D embedded bioprinting.

Although significant breakthroughs have been achieved in constructing complex tissue/organ models in vitro, the progress of 3D bioprinting has long been subjected to trade-offs between the printability and biocompatibility of bioinks. Methacrylated hyaluronic acid (HAMA) has been widely adopted for 3D bioprinting due to its limited immunogenicity and simple synthetic method. However, the challenges arising from HAMA are its limited mechanical properties, low printing resolution, inhomogeneity networks, and the accumulation of reactive oxygen species (ROS) during polymerization. Here, these limitations are addressed by developing a thiol-norbornene photoclick polysaccharide-based bioink (HC-HN), which is prepared through the modification of hyaluronic acid with norbornene functional groups (Nor) and cysteamine hydrochloride (Cys). Compared with traditional HAMA, the HC-HN bioink via a step-growth polymerization mechanism can realize increased viscoelastic properties, reduced ROS accumulation, and superior shape fidelity in a range of complex structures by 3D embedded bioprinting. To further confirm its potential in 3D bioprinting applications, the HC-HN bioink is employed to print a liver model in vitro, which shows higher albumin secretion and urea production. Furthermore, a markedly increased sensitivity to drug-induced hepatotoxicity is observed in the bioprinted liver model compared to the 2D culture. Therefore, the proposed photoclick HC-HN bioink expands the palette of available polysaccharide-based bioinks and greatly extends the biofabrication window to broaden the application opportunities of 3D bioprinting.

The TGM2 Inhibitor Cysteamine Hydrochloride Does Not Impact Corneal Epithelial and Stromal Wound Healing in Vitro and in Vivo

The TGM2 Inhibitor Cysteamine Hydrochloride Does Not Impact Corneal Epithelial and Stromal Wound Healing in Vitro and in Vivo

Studies on Thiol Etching of Gold by Using QCM-D Sensor as the Sacrificial Probe.

There is still a lack of deep understanding on the reaction kinetics and mechanism of thiol etching of gold. Herein, by using the sensor of quartz crystal microbalance (QCM) as the sacrificial probe, the etching reaction of gold has been studied by employing cysteamine (CS) as a typical thiol etchant. The etching reaction is verified as diffusion-controlled and shows a half-order reaction kinetics. It is demonstrated that intact thiol and amino on CS are both crucial for its etching ability to gold. Applied potentials can affect the electron transfer and hence can be used to regulate the gold etching. Our results also reveal that only two carbon atoms of the spacer between thiol and amino on CS are very critical to the excellent etching ability. This work exhibits a new route to explore the thiol etching reaction of gold and elucidates the reaction kinetics and mechanism.

Effect of cysteamine hydrochloride-loaded liposomes on skin depigmenting and penetration

Skin hyperpigmentation is caused by an excessive production of melanin. Cysteamine, an aminothiol compound physiologically synthetized in human body cells, is known as depigmenting agent. The aim of this study was to evaluate the depigmenting activity and skin penetration of liposome formulations encapsulating cysteamine hydrochloride. First, cysteamine hydrochloride-loaded liposomes were prepared and characterized for their size, polydispersity index, zeta potential and the encapsulation efficiency of the active molecule. The stability of cysteamine hydrochloride in the prepared liposome formulations in suspension and freeze-dried forms was then assessed. The in vitro cytotoxicity of cysteamine and cysteamine-loaded liposome suspensions (either original or freeze-dried) was evaluated in B16 murine melanoma cells. The measurement of melanin and tyrosinase activities was assessed after cells treatment with free and encapsulated cysteamine. The antioxidant activity of the free and encapsulated cysteamine was evaluated by the measurement of ROS formation in treated cells. The ex vivo human skin penetration study was also performed using Franz diffusion cell. The stability of cysteamine hydrochloride was improved after encapsulation in liposomal suspension. In addition, for the liposome re-suspended after freeze-drying, a significant increase of vesicle stability was observed. The free and the encapsulated cysteamine in suspension (either original or freeze-dried) did not show any cytotoxic effect, inhibited the melanin synthesis as well as the tyrosinase activity. An antioxidant activity was observed for the free and the encapsulated cysteamine hydrochloride. The encapsulation enhanced the skin penetration of cysteamine hydrochloride. The penetration of this molecule was better for the re-suspended freeze-dried form than the original liposomal suspension where the drug was found retained in the epidermis layer of the skin.

Further insight into the possible influence of electrode blocking agents on the stem-loop based electrochemical DNA sensor parameters

Understanding the electrochemical and interfacial behavior of the biosensor’s recognition layer is crucial for developing devices dedicated to real-life applications. Commonly used binary monolayers with ssDNA as a receptor are also built with 6-mercapto-1-hexanol as an electrode blocking agent (EBA). However, still, poorly reproducible results of such biosensors are reported, especially in the presence of electroactive redox probes freely accessible in measurement buffer. Herein we present investigations on the application of different electrode blocking agents in electrochemical DNA biosensors based on the methylene blue labeled stem-loop-based probe architecture. Electrochemical and working parameters of prepared biosensor were strongly dependent on EBA type used: (i) partial negative charge originated from –OH group in classical mercapto-derivatives of alkanols, 6-mercapto-1-hexanol (MCH) and 2-mercaptoethanol (MCE), (ii) positively charged head group, cysteamine hydrochloride (CHC) (iii) neutral molecule showing two resonance structures, sodium diethyldithiocarbamate, (DEDTC), (iv) differently oriented at the electrode surface aromatic rings, perpendicular to the electrode surface, 2-phenylethanethiol (2-PhET) and significantly tilted, 1,3-benzenedithiol (BDT). Presented investigations show the strong dependence between resonance structures and registered currents. Moreover, because of the improved biosensor’s working parameters and significantly reduced unspecific protein adsorption, DEDTC shows high potential applicability as a new electrode blocking agent during biosensor’s electrochemical sensing layers preparation.

Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a 'Treatabolome'.

Background:Leigh syndrome (LS) is the most frequent paediatric clinical presentation of mitochondrial disease. The clinical phenotype of LS is highly heterogeneous. Though historically the treatment for LS is largely supportive, new treatments are on the horizon. Due to the rarity of LS, large-scale interventional studies are scarce, limiting dissemination of information of therapeutic options to the wider scientific and clinical community.Objective:We conducted a systematic review of pharmacological therapies of LS following the guidelines for FAIR-compliant datasets.Methods:We searched for interventional studies within Clincialtrials.gov and European Clinical trials databases. Randomised controlled trials, observational studies, case reports and case series formed part of a wider MEDLINE search.Results:Of the 1,193 studies initially identified, 157 met our inclusion criteria, of which 104 were carried over into our final analysis. Treatments for LS included very few interventional trials using EPI-743 and cysteamine bitartrate. Wider literature searches identified case series and reports of treatments repleting glutathione stores, reduction of oxidative stress and restoration of oxidative phosphorylation.Conclusions:Though interventional randomised controlled trials have begun for LS, the majority of evidence remains in case reports and case series for a number of treatable genes, encoding cofactors or transporter proteins of the mitochondria. Our findings will form part of the international expert-led Solve-RD efforts to assist clinicians initiating treatments in patients with treatable variants of LS.

Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients

Nephropathic cystinosis is a rare autosomal recessive lysosomal storage disease that is characterized by accumulation of cysteine and formation of crystals within cells of different organs and tissues causing systemic manifestations in childhood that include poor linear growth, ocular involvement, hypothyroidism, and progressive kidney disease. This study was a long‐term, prospective open‐label evaluation of twice‐daily delayed release (DR) cysteamine capsules in cystinosis patients <6 years of age who were naïve to any form of cysteamine treatment. Fifteen treatment‐naïve patients <6 years old (mean age 2.2 ± 1.0 years, 53% male, 73% White) were enrolled and treated with DR‐cysteamine capsules for up to 18 months. Patients had clinically meaningful decreases in WBC cysteine concentration during treatment (3.2 ± 3.0 nmol ½ cystine/mg protein at Day 1 to 0.8 ± 0.8 nmol ½ cystine/mg protein at study exit), and anthropometric data improvements were consistently observed in height, weight and body surface area. Additionally, estimated glomerular filtration rate increased from 55.93 ± 22.43 ml/min/1.73 m2 at baseline to 63.79 ± 21.44 ml/min/1.73 m2 at study exit. Pharmacokinetic/Pharmacodynamic results support the use of the same starting, escalation, and maintenance doses according to body surface for children aged <6 years that are currently recommended in adults and older children. All patients experienced ≥1 adverse event(s) with vomiting (80%) and upper respiratory tract infection (53%) most frequently reported. Based on our study, patients <6 years of age with nephropathic cystinosis without prior treatment can safely and effectively initiate treatment with DR‐cysteamine, a delayed‐release form of cysteamine bitartrate that can be given every 12 h.

Highly selective and sensitive detection of glutathione over cysteine and homocysteine with a turn-on fluorescent biosensor based on cysteamine-stabilized CdTe quantum dots

In this work, cysteamine (CA) stabilized CdTe quantum dots (QDs) (CA-CdTe QDs) and sodium citrate stabilized gold nanoparticles (AuNPs) were prepared. Because of the strong electrostatic interaction and spectral overlap of emission spectrum of CA-CdTe QDs and absorption spectrum of AuNPs, a highly effective fluorescence resonance energy transfer (FRET) system was formed and the fluorescence of CA-CdTe QDs was strongly quenched. The synthesized CA-CdTe and AuNPs were self-assembled to large clusters due to the electrostatic attraction and the fluorescence of CA-CdTe was sharply quenched as a result of FRET. Under the optimum pH of 5.5, the positive GSH could assemble with negative AuNPs through electrostatic interaction and destroy the FRET system of CA-CdTe and AuNPs, due to the red shift of absorption wavelength of AuNPs caused by aggregation. The fluorescence of CA-CdTe recovered, and the recovered fluorescence efficiency shows a linear function against the GSH concentrations from 6.7 nM to 0.40 μM, with a detecting limit of 3.3 nM. The quenched emission of CA-CdTe could be recovered attributed to the aggregation of AuNPs by GSH. Under optimal conditions, the sensing system was successfully applied in the detection of GSH in real human blood plasma samples with a recovery of 99.5–102.3%, showing a promising future for the highly sensitive and selective GSH detection in the human blood plasma samples.